Amplification of KCNMA1 was found in 23 of 1200 breast cancers (1.9%) and was significantly associated with high tumour grade (p<0.001), high tumour cell proliferation (p<0.01) and poor tumour-specific survival (Log-Rank p = 0.031). Here, KCNMA1 is linked to breast cancer.